World's Best Scientists 2026 revealed!
Zbigniew K. Wszolek

Zbigniew K. Wszolek

D-Index & Metrics

Medicine

D-Index
125
Citations
67128
World Ranking
3053
National Ranking
1686

Zbigniew K. Wszolek publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Zbigniew K. Wszolek sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 829 publications — 89th percentile

89% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Zbigniew K. Wszolek D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Zbigniew K. Wszolek sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 125 D-Index — 85th percentile

85% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Zbigniew K. Wszolek is a researcher affiliated with the Mayo Clinic in the United States. Their work spans several interconnected fields with significant contributions primarily in medicine, biochemistry, genetics, molecular biology, and neuroscience. Within these broader areas, their subfields of focus include neurology, molecular biology, physiology, cellular and molecular neuroscience, and genetics.

Their research topics cover a range of neurological and neurodegenerative conditions and mechanisms. Key themes include Parkinson's disease mechanisms and treatments, Alzheimer's disease research and treatments, neuroinflammation and neurodegeneration mechanisms, amyotrophic lateral sclerosis research, neurological diseases and metabolism, RNA regulation and disease, and genetic neurodegenerative diseases.

Zbigniew K. Wszolek has published extensively in several prominent journals. Frequent venues for their publications include Parkinsonism & Related Disorders, Neurology, Neurologia i Neurochirurgia Polska, Alzheimer's & Dementia, and Movement Disorders.

Collaborative efforts feature regular coauthors such as Dennis W. Dickson, Owen A. Ross, Jarosław Dulski, Ryan J. Uitti, and Bradley F. Boeve, with coauthorship counts ranging from 44 to 82 joint publications.

Their recent papers illustrate active engagement in contemporary neurological research:

  • "APOE4 exacerbates synapse loss and neurodegeneration in Alzheimer's disease patient iPSC-derived cerebral organoids," 2020, Nature Communications
  • "Finding genetically-supported drug targets for Parkinson's disease using Mendelian randomization of the druggable genome," 2021, Nature Communications
  • "Utility of the global CDR® plus NACC FTLD rating and development of scoring rules: Data from the ARTFL/LEFFTDS Consortium," 2020, Alzheimer's & Dementia
  • "Inhibition of colony stimulating factor-1 receptor (CSF-1R) as a potential therapeutic strategy for neurodegenerative diseases: opportunities and challenges," 2022, Cellular and Molecular Life Sciences
  • "Safety and efficacy of tilavonemab in progressive supranuclear palsy: a phase 2, randomised, placebo-controlled trial," 2021, The Lancet Neurology

Best Publications

  • Expanded GGGGCC hexanucleotide repeat in noncoding region of C9ORF72 causes chromosome 9p-linked FTD and ALS

    Mariely DeJesus-Hernandez;Ian R. Mackenzie;Bradley F. Boeve;Adam L. Boxer

  • Mutations in LRRK2 Cause Autosomal-Dominant Parkinsonism with Pleomorphic Pathology

    Alexander Zimprich;Alexander Zimprich;Saskia Biskup;Petra Leitner;Peter Lichtner

  • Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease.

    Paul Hollingworth;Denise Harold;Rebecca Sims;Amy Gerrish

  • Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson's disease: a case-control study

    Daniel G Healy;Mario Falchi;Sean S O'Sullivan;Vincenzo Bonifati

  • Mutation-Specific Functional Impairments in Distinct Tau Isoforms of Hereditary FTDP-17

    Ming Hong;Victoria Zhukareva;Vanessa Vogelsberg-Ragaglia;Zbigniew Wszolek

  • Neuropathological assessment of Parkinson's disease: refining the diagnostic criteria.

    Dennis W Dickson;Heiko Braak;John E Duda;Charles Duyckaerts

  • Pathophysiology of REM sleep behaviour disorder and relevance to neurodegenerative disease

    B. F. Boeve;M. H. Silber;C. B. Saper;T. J. Ferman

  • VPS35 Mutations in Parkinson Disease

    Carles Vilariño-Güell;Christian Wider;Owen A. Ross;Justus C. Dachsel

  • Comparison of kindreds with parkinsonism and α‐synuclein genomic multiplications

    Matt Farrer;Jennifer Kachergus;Lysia Forno;Sarah Lincoln

  • DLB and PDD boundary issues: Diagnosis, treatment, molecular pathology, and biomarkers

    C. F. Lippa;J. E. Duda;M. Grossman;H. I. Hurtig

  • Identification of common variants influencing risk of the tauopathy progressive supranuclear palsy

    Günter U. Höglinger;Nadine M. Melhem;Dennis W. Dickson;Patrick M A Sleiman

  • Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration

    Jennifer Gass;Ashley Cannon;Ian R. Mackenzie;Bradley Boeve

  • A susceptibility locus for Parkinson's disease maps to chromosome 2p13

    Thomas Gasser;Bertram Müller-Myhsok;Zbigniew K. Wszolek;Ralph Oehlmann

  • TIA1 Mutations in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Promote Phase Separation and Alter Stress Granule Dynamics

    Ian R. Mackenzie;Alexandra M. Nicholson;Mohona Sarkar;James Messing

  • Identification of a Novel LRRK2 Mutation Linked to Autosomal Dominant Parkinsonism: Evidence of a Common Founder across European Populations

    Jennifer Kachergus;Ignacio F. Mata;Mary Hulihan;Julie P. Taylor

  • Pathogenic implications of mutations in the tau gene in pallido-ponto-nigral degeneration and related neurodegenerative disorders linked to chromosome 17

    Lorraine N. Clark;Parvoneh Poorkaj;Zbigniew Wszolek;Daniel H. Geschwind

  • Pharmacological Rescue of Mitochondrial Deficits in iPSC-Derived Neural Cells from Patients with Familial Parkinson’s Disease

    Oliver Cooper;Hyemyung Seo;Shaida Andrabi;Cristina Guardia-Laguarta

  • Mutations in the colony stimulating factor 1 receptor ( CSF1R ) gene cause hereditary diffuse leukoencephalopathy with spheroids

    Rosa Rademakers;Matt Baker;Alexandra M Nicholson;Nicola J Rutherford

  • Accumulation of Pathological Tau Species and Memory Loss in a Conditional Model of Tauopathy

    Zdenek Berger;Hanno Roder;Amanda Hanna;Aaron Carlson

  • Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis.

    Nicola J. Rutherford;Yong-Jie Zhang;Matt Baker;Jennifer M Gass

Frequent Co-Authors

Ryan J. Uitti
Ryan J. Uitti Mayo Clinic
Owen A. Ross
Owen A. Ross Mayo Clinic
Rosa Rademakers
Rosa Rademakers University of Antwerp
Matthew J. Farrer
Matthew J. Farrer University of Florida
Bradley F. Boeve
Bradley F. Boeve Mayo Clinic
David S. Knopman
David S. Knopman Mayo Clinic
Ronald C. Petersen
Ronald C. Petersen University of Pennsylvania
Kejal Kantarci
Kejal Kantarci Mayo Clinic

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Alongside traditional medical degrees, there are many rewarding careers in healthcare that you can begin or advance online. For example, those interested in administrative roles may consider programs from the online health administration programs, which offer accelerated paths to management positions in hospitals and clinics.

If you are drawn to patient care but do not wish to become a doctor, there are opportunities such as licensed practical nursing. Some schools now offer an lpn school without teas test requirement, helping more students start nursing careers without major entrance barriers.

For those interested in the business side of healthcare, the best medical billing and coding schools online provide flexible paths into high-demand health IT fields, often with financial aid availability.

Registered nurses aiming for advanced practice can choose from rn to fnp bridge programs, which help nurses earn a master's degree and become Family Nurse Practitioners, all through accelerated online study.

Best Scientists Citing Zbigniew K. Wszolek

Trending Scientists

Recently Published Articles